FDA Inspection 1050213 — Biopharmaceutics Research Institute
The FDA completed an inspection of Biopharmaceutics Research Institute on Mar 29, 2018 in Grahamstown. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 29, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Grahamstown (South Africa)
Additional Details
In Vivo Bioequivalence